3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Pancreatic Neoplasms
6
Neoplasms
6
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Leukemia, Myeloid, Acute
5
Head and Neck Neoplasms
5
Urinary Bladder Neoplasms
4
Multiple Myeloma
4
Lung Neoplasms
4
Leukemia
4
Colorectal Neoplasms
4
Recurrence
3
Neoplasms, Plasma Cell
3
Hematologic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Rectal Neoplasms
2
Radiodermatitis
2
Neoplasms by Site
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Melanoma
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Communication
2
Carcinoma, Transitional Cell
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Interventions
antineoplaston AS 2-1
3
antineoplaston A10
3
dactolisib
2
Temozolomide
2
Irinotecan
2
Everolimus
2
Bevacizumab
2
surufatinib
1
spartalizumab
1
poly ICLC
1
plerixafor
1
pasireotide
1
fosbretabulin
1
cixutumumab
1
adavosertib
1
Vaccines
1
TH 302
1
Sunitinib
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation
1
PM 00104
1
Lapatinib
1
Immunologic Techniques
1
Immunoglobulin G
1
Genistein
1
Fentanyl
1
Donepezil
1
Disulfides
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive
×
Standard of Care
×
Clear all
No trials found.